Allergan plc (NYSE: AGN) is a large market cap stock with a market cap of 100626.75. It is in the Drugs – Generic industry and sector Healthcare, with a current P/E of *TBA, a forward P/E of 14.76 and EPS of -5.63. At a stock price of 253.58 (-0.77%) it has a dividend yield of *TBA.
EPS growth for the last five years have been -50.40%, more recently this last year it has grown by 23.00%. The next year growth is going to be about 22.45% and more long-term 9.70% after five years. EPS growth quarter over quarter is 86.30%. Sales growth for the past five years have been 33.40% and sales growth quarter over quarter is 48.10%.
For performance, Allergan plc the past week has seen a gain of 3.11%. For the last month performance for Allergan plc is 12.23%. While the last quarter is 16.77% and half year, -9.30%. Finally for the year, performance is -24.39%.
The 52-week high for Allergan plc, is at -25.49%, and for the 52-week low it comes to a value of 29.71%. The 20-day simple moving average is 6.20% and -5.54% for the 200-day simple moving average.
Volatility for the week is at 2.22%, and for the month it is 2.00%. Allergan plc, has a target price of 293.06.
In terms of debt, long term debt/equity is 0.53, and for total debt/equity Allergan plc has 0.59. The gross margin is 71.80%, while operating margin is *TBA, the profit margin is *TBA. The current ratio is 1 and the quick ratio is 0.9.
Insider ownership is at 0.10%, with instituitional ownership at 89.80%. Allergan plc has a payout ratio of *TBA. With the total shares outstanding coming to 393.75. The shares float is 393.75, with the float short at 1.47%, with short ratio coming to 1.6.
In terms of returns, the return on assets see Allergan plc, get *TBA, with its returns on investment at -1.30%. Return on equity is *TBA. So will the investors see the target price of 293.06, reached soon?
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.